Additional file 2 of Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

Additional file 2: sFig. 1. Comparing the differences in the performance of predicting pCR with different clinical factors, SNV and CNV characters. sFig. 2. (A) Sankey plot showing the differences in patients ctDNA cleared at different time points (T1, T2, T3). (B) Sankey plot showing the differences in patients with positive ctDNA at different time points (T1, T2, T3). sFig. 3. Kaplan–Meier analysis of DFS stratified based on ctDNA status during NAC. sFig 4. Overall algorithm flowchart for the predictive model construction.